CCL18 expression levels in the kidneys of type 2 diabetic nephropathy patients and in the abdominal subcutaneous fat and visceral fat of obese patients were not significantly different from those in the control groups (p > 0.05) (Figure 6a,b and Supplementary Table S2 and Supplementary Table S3). Here, CCL18 is linked to type 2 diabetes nephropathy.